About AFNET
MISSION STATEMENT
Mission statement of AFNET
The mission of AFNET is to improve the lives of patients with cardiovascular diseases by generating knowledge on their mechanisms and evidence on effective and safe treatments.
The results of clinical and translational research have significantly improved the lives of patients with cardiovascular disease. However, cardiovascular disease remains a major cause of premature death and increased morbidity. The aim of AFNET is to generate knowledge and new insights to improve the treatment of cardiovascular diseases.
To achieve this, AFNET provides a platform to plan and execute non-commercial, international, investigator-initiated controlled clinical trials, registries, and translational research projects that can inform better care of patients with cardiovascular disease.
AFNET cooperates with selected partners to conduct its projects. Funding is obtained trough public and/or private partnerships. AFNET has long expertise in the management of atrial fibrillation, but also provides support for research in other fields informing cardiovascular care.
Our Vision for the next 20 years
- Improving synergy between researchers and bringing science and society closer together
- Extending our scientific network and strengthening international cooperations
- Increasing the number of public grants and private sector investments to fund innovative research projects
- Conducting international randomized clinical trials with impact on clinical guidelines
- Increasing the number of publications in high impact scientific journals
- Developing a data hub harmonizing information collected from different studies
- Optimizing treatment strategies and treatment decisions to improve the lives of our patients with atrial fibrillation and to promote cardiovascular health